Glycolic Acid

Glycolic Acid

SCHEMBL1373369

Cl.O=C(O)CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Glycolic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycolic Acid SCHEMBL9462736 0.95
Glycolic Acid SCHEMBL27501769 0.95
Glycolic Acid SCHEMBL9178990 0.95 OR51E2 (0.44)
Glycolic Acid SCHEMBL2518351 0.95 LMNA (0.50)
Glycolic Acid SCHEMBL1222 0.95
Glycolic Acid SCHEMBL11698763 0.95 LMNA (0.50)
Glycolic Acid SCHEMBL6362687 0.95
Glycolic Acid SCHEMBL1331333 0.95
Glycolic Acid SCHEMBL811403 0.95 LMNA (0.50)
Glycolic Acid SCHEMBL5074103 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5378797-A Process for preparing aliphatic polyesters SHELL OIL COMPANY (US) 1995-01-03 US claimed
CN-120076809-A Combination therapy of CDK7 inhibitors with other anti-cancer therapies 奎利恩特有限公司 2025-05-30 CN disclosed
CN-119032181-A Modified sophorolipids for improving the bioavailability of amino acids and methods of use 轨迹方案IPCO有限责任公司 2024-11-26 CN disclosed
US-20240058234-A1 COMPOSITIONS AND RELATED METHODS COLGATE-PALMOLIVE COMPANY 2024-02-22 US disclosed
CN-110337442-B Novel glucose derivatives as inhibitors of sodium-dependent glucose transporter type 2 东亚ST株式会社 2023-05-12 CN disclosed
CN-113480580-A Method for selectively and efficiently extracting licorice residue flavone and co-producing biomethane 华南农业大学 2021-10-08 CN disclosed
WO-2020242253-A1 NOVEL EMPAGLIFLOZIN DERIVATIVE WHICH IS SGLT-2 INHIBITOR 동아에스티 주식회사 2020-12-03 WO disclosed
CN-109574897-B (Z) -beta-selenocyanatyl propenone compound and synthetic method thereof 湖南科技学院 2020-09-04 CN disclosed
CN-109438309-B Z-2-selenocyanatyl alkenyl aryl sulfone compound and synthetic method thereof 湖南科技学院 2020-08-07 CN disclosed
CN-109438308-B (Z) - β -selenocyanatopropylthioate compound and synthetic method thereof 湖南科技学院 2020-08-04 CN disclosed
WO-2007016012-A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION WYETH (US) 2007-02-08 WO disclosed
US-20070027199-A1 Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation WYETH (US) 2007-02-01 US disclosed
CN-1829827-A Electrode for electrochemical processes and method for producing the same DE NORA ELETTRODI SPA (IT) 2006-09-06 CN disclosed
CN-1179159-A Guanine derivatives WELLCOME FOUND (GB) 1998-04-15 CN disclosed
EP-0665858-B1 PROCESS FOR PREPARING ALIPHATIC POLYESTERS SHELL INT RESEARCH (NL) 1998-01-21 EP disclosed
US-5616798-A 2,2',4,4'6,6'-HEXAAMIDO-3,3',5,5'-TETRAIODOBIPHENYLS; RADIOLOGY GUERBET S.A. (FR) 1997-04-01 US disclosed
EP-0665858-A1 PROCESS FOR PREPARING ALIPHATIC POLYESTERS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1995-08-09 EP disclosed
US-5378797-A Process for preparing aliphatic polyesters SHELL OIL COMPANY (US) 1995-01-03 US disclosed
WO-1994009054-A1 PROCESS FOR PREPARING ALIPHATIC POLYESTERS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1994-04-28 WO disclosed
US-4036984-A PHENOXYETHYL FATTY ACID ESTER NISSAN CHEMICAL INDUSTRIES, LTD. (JA) 1977-07-19 US disclosed